Your browser doesn't support javascript.
loading
TNFR2 Costimulation Differentially Impacts Regulatory and Conventional CD4+ T-Cell Metabolism.
Mensink, Mark; Tran, Thi Ngoc Minh; Zaal, Esther A; Schrama, Ellen; Berkers, Celia R; Borst, Jannie; de Kivit, Sander.
Afiliação
  • Mensink M; Department of Immunology and Oncode Institute, Leiden University Medical Center, Leiden, Netherlands.
  • Tran TNM; Division of Cell Biology, Metabolism & Cancer, Department Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.
  • Zaal EA; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, Netherlands.
  • Schrama E; Division of Cell Biology, Metabolism & Cancer, Department Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.
  • Berkers CR; Department of Immunology and Oncode Institute, Leiden University Medical Center, Leiden, Netherlands.
  • Borst J; Division of Cell Biology, Metabolism & Cancer, Department Biomolecular Health Sciences, Faculty of Veterinary Medicine, Utrecht University, Utrecht, Netherlands.
  • de Kivit S; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht University, Utrecht, Netherlands.
Front Immunol ; 13: 881166, 2022.
Article em En | MEDLINE | ID: mdl-35844585
ABSTRACT
CD4+ conventional T cells (Tconvs) mediate adaptive immune responses, whereas regulatory T cells (Tregs) suppress those responses to safeguard the body from autoimmunity and inflammatory diseases. The opposing activities of Tconvs and Tregs depend on the stage of the immune response and their environment, with an orchestrating role for cytokine- and costimulatory receptors. Nutrient availability also impacts T-cell functionality via metabolic and biosynthetic processes that are largely unexplored. Many data argue that costimulation by Tumor Necrosis Factor Receptor 2 (TNFR2) favors support of Treg over Tconv responses and therefore TNFR2 is a key clinical target. Here, we review the pertinent literature on this topic and highlight the newly identified role of TNFR2 as a metabolic regulator for thymus-derived (t)Tregs. We present novel transcriptomic and metabolomic data that show the differential impact of TNFR2 on Tconv and tTreg gene expression and reveal distinct metabolic impact on both cell types.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T Reguladores / Receptores Tipo II do Fator de Necrose Tumoral Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfócitos T Reguladores / Receptores Tipo II do Fator de Necrose Tumoral Idioma: En Ano de publicação: 2022 Tipo de documento: Article